Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REAL-AID: NSAIDs to Reduce Laryngeal Edema After Alluminox Photoimmunotherapy
jRCTs031250140Recruiting
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of celecoxib and flurbiprofen axetil in head and neck cancer (HNC) (2 cohorts). Primary endpoint: Degree of laryngeal edema at 24 hours after laser light illumination (central assessment). Started Jun 2025; status: recruiting.
02
Drugs
celecoxibflurbiprofen axetil
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on jRCTs031250140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250140.